Q4 2025 Holdings
Filed 2026-02-17 | 9 holdings | $651.7M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Maze Therapeutics Inc.(MAZE) | COM | 578784100 | $170.7M | 4,120,053 | 26.2% |
| Beam Therapeutics Inc.(BEAM) | COM | 07373V105 | $125.9M | 4,540,132 | 19.3% |
| Rapport Therapeutics Inc.(RAPP) | COM | 75383L102 | $113.1M | 3,728,738 | 17.4% |
| Lyell Immunopharma Inc.(LYEL) | COM NEW | 55083R203 | $84.9M | 2,759,072 | 13.0% |
| VIR Biotechnology Inc.(VIR) | COM | 92764N102 | $77.9M | 12,916,663 | 12.0% |
| Erasca Inc.(ERAS) | COM | 29479A108 | $41.1M | 11,055,554 | 6.3% |
| Gossamer BIO Inc.(GOSS) | COM | 38341P102 | $25.0M | 8,055,916 | 3.8% |
| 10X Genomics Inc.(TXG) | CL A COM | 88025U109 | $12.0M | 737,539 | 1.8% |
| Q32 BIO Inc.(QTTB) | COM | 746964105 | $1.1M | 320,482 | 0.2% |